Asset Details
Do you wish to reserve the book?
Alginate oligosaccharides enhance diffusion and activity of colistin in a mucin-rich environment
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Alginate oligosaccharides enhance diffusion and activity of colistin in a mucin-rich environment
Do you wish to request the book?
Alginate oligosaccharides enhance diffusion and activity of colistin in a mucin-rich environment
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Alginate oligosaccharides enhance diffusion and activity of colistin in a mucin-rich environment
2022
Overview
In a number of chronic respiratory diseases e.g. cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), the production of viscous mucin reduces pulmonary function and represents an effective barrier to diffusion of inhaled therapies e.g. antibiotics. Here, a 2-compartment Transwell model was developed to study impaired diffusion of the antibiotic colistin across an artificial sputum (AS) matrix/medium and to quantify its antimicrobial activity against
Pseudomonas aeruginosa
NH57388A biofilms (alone and in combination with mucolytic therapy). High-performance liquid chromatography coupled with fluorescence detection (HPLC-FLD) revealed that the presence of AS medium significantly reduced the rate of colistin diffusion (> 85% at 48 h;
p
< 0.05). Addition of alginate oligosaccharide (OligoG CF-5/20) significantly improved colistin diffusion by 3.7 times through mucin-rich AS medium (at 48 h;
p
< 0.05). Increased diffusion of colistin with OligoG CF-5/20 was shown (using confocal laser scanning microscopy and COMSTAT image analysis) to be associated with significantly increased bacterial killing (
p
< 0.05). These data support the use of this model to study drug and small molecule delivery across clinically-relevant diffusion barriers
.
The findings indicate the significant loss of colistin and reduced effectiveness that occurs with mucin binding, and support the use of mucolytics to improve antimicrobial efficacy and lower antibiotic exposure.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ Anti-Bacterial Agents - pharmacology
/ Anti-Bacterial Agents - therapeutic use
/ Biofilms
/ Chronic obstructive pulmonary disease
/ Colistin
/ Cystic Fibrosis - microbiology
/ High-performance liquid chromatography
/ Humanities and Social Sciences
/ Humans
/ Mucin
/ Oligosaccharides - chemistry
/ Pseudomonas Infections - drug therapy
/ Science
/ Sputum
